The world set a 75% malaria reduction target for 2025. The global rate went up instead.

In May 2015, the World Health Assembly — all WHO member states — adopted the Global Technical Strategy for Malaria 2016–2030. The strategy established an intermediate 2025 milestone: cut global malaria incidence and mortality rates by at least 75% compared to 2015. The 2025 checkpoint was designed as an early signal of whether the eventual 90% reduction target, due in 2030, was reachable. The strategy was updated in 2021 and its milestones were maintained. The WHO Global Health Observatory tracks malaria incidence as estimated cases per 1,000 population at risk — the metric the strategy uses. The December 2025 vintage of that series, underpinning the World Malaria Report 2025 published the same month, covers data through 2024. The global malaria incidence rate stood at 59.01 per 1,000 population at risk in 2015. By 2024 it had risen to 63.95 — an 8.4% increase. Meeting the 75% reduction milestone would have required the rate to fall to 14.75 or below. The actual 2024 rate is 4.3 times that threshold. Among the 89 countries that recorded a positive 2015 incidence rate and have a 2024 WHO estimate, 16 cleared the 75% reduction milestone. The other 73 did not: 34 saw their rates rise, and 39 declined but by less than 75%. [verified, WHO GHO MALARIA_EST_INCIDENCE, December 2025 vintage] The same pattern holds for deaths. The WHO World Malaria Report 2025 estimates 610,000 malaria deaths globally in 2024, up from 438,000 in 2015 ^mmodeled — a 39% increase in absolute deaths. The report states the 2024 malaria mortality rate is more than three times the 2025 milestone target. Of the three GTS milestones, the elimination target was already met: the strategy called for malaria eliminated in at least 10 countries by 2025, and since its adoption 14 countries have received WHO malaria-free certification — including China (2021), El Salvador (2021), Belize (2023), Cabo Verde (2024), and Georgia (2025). For the two rate milestones, the latest available 2024 data left the world far off the 2025 targets. [verified, WHO certification record]

The following is analysis, not fact. The global trajectory appears to be heavily shaped by a single region ^mmodeled. The WHO African Region carries 94% of the world's malaria cases, and its own incidence rate barely moved — from 243.2 per 1,000 in 2015 to 237.6 in 2024, a 2.3% decline against a 75% target. The 20 countries with the highest 2015 incidence rates are all in Africa, each above 260 per 1,000. Among them, 4 — Democratic Republic of Congo, Nigeria, Burundi, and Malawi — saw their rates increase. Of the 16 that declined, only Rwanda approached the milestone, cutting its rate by 74.96% — from 308.04 to 77.14 per 1,000, a fraction below the threshold; the rest ranged from under 4% (Cameroon) to 46% (Liberia). Rwanda's result is consistent with ^sspeculative sustained national investment in surveillance, treatment coverage, and net distribution across the same period. The 16 countries that cleared the 75% milestone divide into two groups. Twelve had 2015 incidence rates below 1 per 1,000 at risk — they were already approaching elimination. The 4 that cleared it from higher baselines — 2015 rates above 1 per 1,000 at risk — were Cambodia (19.7 → near zero), Laos (17.7 → near zero), Zimbabwe (94 → 11, −88%), and India (6.4 → 1.5, −77%). The WHO South-East Asia Region moved from 6.2 to 1.9 per 1,000 — a 69% decline; India, the region's dominant population, cut its own rate 77% (6.4 → 1.5) over the same span. The Eastern Mediterranean ran in the opposite direction: its regional rate more than doubled, from 9.0 to 19.1 per 1,000. Sudan's rate rose 127%, Yemen's 101%, Pakistan's 173%. The pattern is consistent with ^sspeculative the collapse of national malaria control programs in conflict-affected settings. The global trajectory also marks a pivot year. From 2015 through 2019, the global rate edged modestly lower, from 59.0 to 58.0 per 1,000. Since 2019 it has risen 10%, reaching 63.95 by 2024. Against that trajectory — the latest WHO data runs through 2024 — the world was left far off track for the 2025 milestone, not just in the final measured year but across the decade.

The steelmanned counter is structural: the 75% milestone was designed without anticipating COVID-19. The pandemic disrupted bed-net distribution, suppressed care-seeking, and diverted health infrastructure across high-burden countries — on that reading, the visible plateau and reversal in global incidence around 2020 is not simply an accountability failure ^sspeculative. Rwanda's 74.96% reduction — missing the milestone by 0.04 percentage points from a 2015 rate of 308.04 per 1,000 — is consistent with the target having been nearly attainable from high endemicity in at least one case ^sspeculative; a single country cannot establish that it was generally feasible. The WHO World Malaria Report 2025 attributes part of recent progress to new tools — including the R21 vaccine rolled out in high-burden countries from 2023. The WHO's 2030 target of 90% reduction remains in force; the 2025 checkpoint is a course-correction signal for a decade that has not ended.

Health ministries across the WHO African Region operate with the funding shortfall in plain view: the WHO World Malaria Report 2025 puts available malaria financing in 2024 at $3.9 billion against the GTS target of $9.3 billion — less than half. That shortfall is a global figure, not a per-country measure — but it is the fiscal backdrop against which high-burden health ministries run their malaria programs. From that position, a 75% milestone set in 2015 can read as a commitment that was never fully provisioned ^sspeculative. The strategy's architects would likely counter that the funding gap is itself the failure — not an excuse for missing the target it was designed to fund ^sspeculative.